GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

FAQ

What is the symbol for Acer Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Acer Therapeutics Inc. is ACER and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Acer Therapeutics Inc. Stock?
Acer Therapeutics Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Acer Therapeutics Inc. Stock?
Acer Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Acer Therapeutics Inc. Stock.

What's the current price of Acer Therapeutics Inc. Stock?
As of the end of day on the 2024-02-16, the price of an Acer Therapeutics Inc. (ACER) share was $0.660.

What is the 52-week high and low for Acer Therapeutics Inc. Stock?
The 52-week high for Acer Therapeutics Inc. Stock is $2.35 and the 52-week low is $0.552.

What is the market capitalization of Acer Therapeutics Inc. Stock?
As of the 2024-02-16, the market capitalization of Acer Therapeutics Inc. is 16.148M.

When is the next earnings date for Acer Therapeutics Inc.?
The upcoming earnings date for Acer Therapeutics Inc. is May 13, 2024.
Click to get the best stock tips daily for free!

About Acer Therapeutics Inc.

Acer Therapeutics. Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mutation; ACER-001, a formulation of sodium phenylbutyrate for the treatment of various inborn errors of ... ACER Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT